Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Bliss GVS Pharma Ltd.
Swot
Bliss GVS Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Bliss GVS Pharma Ltd. has 23 Strengths, 6 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(23)
Weakness
(6)
Opportunity
(4)
Threats
(0)
Others
(3)
Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Best Bargains Screener: Above line growth, Below line valuations
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
High Volume, High Gain
Top Gainers
Volume Shockers
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
MACD Crossover Below Signal Line
Companies with growing costs YoY for long term projects
Decline in Quarterly Net Profit (YoY)
Red Flag: Resignation of Top Management
MACD crossed below signal line previous end of day
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
